Accumulating evidence clearly indicates that high HSF1 levels effectively maintain protein stability in the hypermetabolic environment of tumor cells, and cancer cells have also been described as having a "nononcogenic" dependence on HSF1. This evidence concerns the gene HSF1 and cancer.